Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study
Summary Background Early complicated Crohn's disease (CD) may require ileal resection as first‐line treatment. Aim To evaluate the long‐term outcomes of patients who underwent early ileal resection. Methods We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral cen...
Saved in:
Published in | Alimentary pharmacology & therapeutics Vol. 60; no. 10; pp. 1388 - 1397 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.11.2024
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Summary
Background
Early complicated Crohn's disease (CD) may require ileal resection as first‐line treatment.
Aim
To evaluate the long‐term outcomes of patients who underwent early ileal resection.
Methods
We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging).
Results
Among 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4–35.2]), than the intermediate (16.8% [95% CI 10.5–26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1–33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02).
Conclusion
Early ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences.
Early ileal resection for Crohn's disease within the first 6 months of diagnosis is not associated with a higher risk of re‐resection compared with late resection. On the contrary, patients who undergo early resection may require fewer postoperative treatments and have less evidence of disease recurrence on endoscopy and imaging. |
---|---|
AbstractList | Early complicated Crohn's disease (CD) may require ileal resection as first-line treatment.
To evaluate the long-term outcomes of patients who underwent early ileal resection.
We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging).
Among 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4-35.2]), than the intermediate (16.8% [95% CI 10.5-26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1-33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02).
Early ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences. Summary Background Early complicated Crohn's disease (CD) may require ileal resection as first‐line treatment. Aim To evaluate the long‐term outcomes of patients who underwent early ileal resection. Methods We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging). Results Among 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4–35.2]), than the intermediate (16.8% [95% CI 10.5–26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1–33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively ( p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group ( p = 0.02). Conclusion Early ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences. Summary Background Early complicated Crohn's disease (CD) may require ileal resection as first‐line treatment. Aim To evaluate the long‐term outcomes of patients who underwent early ileal resection. Methods We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging). Results Among 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4–35.2]), than the intermediate (16.8% [95% CI 10.5–26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1–33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02). Conclusion Early ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences. Early ileal resection for Crohn's disease within the first 6 months of diagnosis is not associated with a higher risk of re‐resection compared with late resection. On the contrary, patients who undergo early resection may require fewer postoperative treatments and have less evidence of disease recurrence on endoscopy and imaging. BackgroundEarly complicated Crohn's disease (CD) may require ileal resection as first‐line treatment.AimTo evaluate the long‐term outcomes of patients who underwent early ileal resection.MethodsWe conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging).ResultsAmong 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4–35.2]), than the intermediate (16.8% [95% CI 10.5–26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1–33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02).ConclusionEarly ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences. Background: Early complicated Crohn's disease (CD) may require ileal resection as first-line treatment.Aim: To evaluate the long-term outcomes of patients who underwent early ilealresection.Methods: We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or re-currence on imaging).Results: Among 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4–35.2]), than the intermediate (16.8% [95%CI 10.5–26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1–33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02).Conclusion: Early ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences. Early complicated Crohn's disease (CD) may require ileal resection as first-line treatment.BACKGROUNDEarly complicated Crohn's disease (CD) may require ileal resection as first-line treatment.To evaluate the long-term outcomes of patients who underwent early ileal resection.AIMTo evaluate the long-term outcomes of patients who underwent early ileal resection.We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging).METHODSWe conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging).Among 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4-35.2]), than the intermediate (16.8% [95% CI 10.5-26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1-33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02).RESULTSAmong 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4-35.2]), than the intermediate (16.8% [95% CI 10.5-26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1-33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02).Early ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences.CONCLUSIONEarly ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences. |
Author | Lefèvre, Jérémie H. Treton, Xavier Beaugerie, Laurent Grellier, Nathan Sokol, Harry Stefanescu, Carmen Seksik, Philippe Panis, Yves Kirchgesner, Julien Uzzan, Mathieu Mclellan, Paul |
Author_xml | – sequence: 1 givenname: Nathan orcidid: 0000-0002-0452-3218 surname: Grellier fullname: Grellier, Nathan organization: Sorbonne Université, INSERM, APHP, Hôpital Saint‐Antoine – sequence: 2 givenname: Julien orcidid: 0000-0002-2314-9284 surname: Kirchgesner fullname: Kirchgesner, Julien organization: Sorbonne Université, INSERM, APHP, Hôpital Saint‐Antoine – sequence: 3 givenname: Mathieu surname: Uzzan fullname: Uzzan, Mathieu organization: Mondor Hospital – sequence: 4 givenname: Paul surname: Mclellan fullname: Mclellan, Paul organization: Sorbonne Université, INSERM, APHP, Hôpital Saint‐Antoine – sequence: 5 givenname: Carmen surname: Stefanescu fullname: Stefanescu, Carmen organization: Paris IBD Center, Groupe Hospitalier Privé Ambroise Pare‐Hartmann – sequence: 6 givenname: Jérémie H. surname: Lefèvre fullname: Lefèvre, Jérémie H. organization: Saint‐Antoine Hospital – sequence: 7 givenname: Xavier surname: Treton fullname: Treton, Xavier organization: Paris IBD Center, Groupe Hospitalier Privé Ambroise Pare‐Hartmann – sequence: 8 givenname: Yves surname: Panis fullname: Panis, Yves organization: Paris IBD Center, Groupe Hospitalier Privé Ambroise Pare‐Hartmann – sequence: 9 givenname: Harry orcidid: 0000-0002-2914-1822 surname: Sokol fullname: Sokol, Harry organization: Sorbonne Université, INSERM, APHP, Hôpital Saint‐Antoine – sequence: 10 givenname: Laurent surname: Beaugerie fullname: Beaugerie, Laurent organization: Sorbonne Université, INSERM, APHP, Hôpital Saint‐Antoine – sequence: 12 givenname: Philippe orcidid: 0000-0003-3596-9893 surname: Seksik fullname: Seksik, Philippe email: philippe.seksik@aphp.fr organization: Sorbonne Université, INSERM, APHP, Hôpital Saint‐Antoine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39234950$$D View this record in MEDLINE/PubMed https://hal.science/hal-04691632$$DView record in HAL |
BookMark | eNp1kcFq3DAQhkVJaDZpDn2BIuih6cHJSLItubdl2TaBhZayOQtZHneV2tZWkhP2lkfoM_ZJ6mTTFAqdy8Dw8c8M3zE5GPyAhLxmcM6mujDbdM4Uz-ULMmOiLDIOojwgM-BllXHFxBE5jvEGAEoJ_CU5EhUXeVXAjHxfmtDtqOvQdDRgRJucH6gb6CL4zfAu0sZFNBGpi3TwiZoYvXUmYUPvXNrQiLcYkHZ--Pbr_mfC0FM_Jut7jB_oeoN0-fVqQWMam90rctiaLuLpUz8h1x-X68Vltvr86WoxX2VWMC4z0ygAZatCWZZLK8EWBpVStW0ApBK2kHXJS1EDUzIvjMzztmZNi6bBVplWnJD3-9yN6fQ2uN6EnfbG6cv5Sj_MIC8rVgp-yyb2bM9ug_8xYky6d9Fi15kB_Ri1YAAVU0rkE_r2H_TGj2GYPpkoVknBS4C_y23wMQZsny9goB9s6cmWfrQ1sW-eEse6x-aZ_KNnAi72wN0kaPf_JD3_st5H_gbwLJ-G |
Cites_doi | 10.1016/0016-5085(90)90613-6 10.1016/S2468-1253(20)30117-5 10.1111/codi.15813 10.1136/gutjnl-2017-315568 10.1093/ecco-jcc/jjy113 10.3390/jcm10040731 10.1016/S0140-6736(17)32448-0 10.1016/j.cgh.2021.06.035 10.1097/MEG.0000000000001206 10.1016/j.dld.2022.09.016 10.1007/s00384-018-2995-9 10.1016/j.cgh.2019.12.036 10.1016/j.crohns.2009.09.009 10.1093/bjsopen/zrad097 10.1111/j.1365-2036.2007.03515.x 10.1136/gutjnl-2018-317539 10.1038/ajg.2012.298 10.1007/s00330-008-1034-6 10.1053/j.gastro.2011.01.055 10.1016/S0140-6736(16)31711-1 10.1016/S2468-1253(17)30248-0 10.1053/j.gastro.2023.05.051 |
ContentType | Journal Article |
Copyright | 2024 The Author(s). published by John Wiley & Sons Ltd. 2024 The Author(s). Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd. 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Attribution - NoDerivatives |
Copyright_xml | – notice: 2024 The Author(s). published by John Wiley & Sons Ltd. – notice: 2024 The Author(s). Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd. – notice: 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Attribution - NoDerivatives |
CorporateAuthor | ERIC Study group the ERIC Study group |
CorporateAuthor_xml | – name: ERIC Study group – name: the ERIC Study group |
DBID | 24P WIN CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TK 7U9 H94 M7N 7X8 1XC VOOES |
DOI | 10.1111/apt.18247 |
DatabaseName | Wiley-Blackwell Open Access Collection Wiley Online Library Journals Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts Neurosciences Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts Virology and AIDS Abstracts Neurosciences Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2036 |
EndPage | 1397 |
ExternalDocumentID | oai_HAL_hal_04691632v1 10_1111_apt_18247 39234950 APT18247 |
Genre | researchArticle Multicenter Study Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DTERQ E3Z EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN EST ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FZ0 G-S G.N GODZA GX1 H.X HF~ HGLYW HVGLF HZI HZ~ IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK0 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TR2 TUS UB1 V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YOC ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TK 7U9 H94 M7N 7X8 1XC VOOES |
ID | FETCH-LOGICAL-c3127-ad8008c958c147c70c5ae888bcd00783c57b6263b018745a744fb1dfeadef8af3 |
IEDL.DBID | DR2 |
ISSN | 0269-2813 1365-2036 |
IngestDate | Sat Nov 09 06:43:34 EST 2024 Thu Oct 24 16:46:21 EDT 2024 Thu Oct 24 14:31:10 EDT 2024 Wed Oct 30 12:26:57 EDT 2024 Sat Nov 02 12:18:47 EDT 2024 Thu Oct 24 09:52:40 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Crohn 's disease Surgery IBD |
Language | English |
License | Attribution-NonCommercial-NoDerivs 2024 The Author(s). Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd. Attribution - NoDerivatives: http://creativecommons.org/licenses/by-nd |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3127-ad8008c958c147c70c5ae888bcd00783c57b6263b018745a744fb1dfeadef8af3 |
Notes | The Handling Editor for this article was Professor Richard Gearry, and it was accepted for publication after full peer‐review. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-3596-9893 0000-0002-0452-3218 0000-0002-2914-1822 0000-0002-2314-9284 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fapt.18247 |
PMID | 39234950 |
PQID | 3119732600 |
PQPubID | 2045200 |
PageCount | 10 |
ParticipantIDs | hal_primary_oai_HAL_hal_04691632v1 proquest_miscellaneous_3100918834 proquest_journals_3119732600 crossref_primary_10_1111_apt_18247 pubmed_primary_39234950 wiley_primary_10_1111_apt_18247_APT18247 |
PublicationCentury | 2000 |
PublicationDate | November 2024 |
PublicationDateYYYYMMDD | 2024-11-01 |
PublicationDate_xml | – month: 11 year: 2024 text: November 2024 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Chichester |
PublicationTitle | Alimentary pharmacology & therapeutics |
PublicationTitleAlternate | Aliment Pharmacol Ther |
PublicationYear | 2024 |
Publisher | Wiley Subscription Services, Inc Wiley |
Publisher_xml | – name: Wiley Subscription Services, Inc – name: Wiley |
References | 2020; 5 2021; 10 1990; 99 2017; 2 2021; 23 2023; 55 2023; 7 2019; 68 2019; 13 2008; 18 2023; 165 2021; 19 2017; 390 2018; 30 2022; 20 2011; 140 2018; 33 2017; 389 2010; 4 2012; 107 2007; 26 e_1_2_10_12_1 e_1_2_10_23_1 e_1_2_10_9_1 e_1_2_10_13_1 e_1_2_10_10_1 e_1_2_10_21_1 e_1_2_10_11_1 e_1_2_10_22_1 e_1_2_10_20_1 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_7_1 e_1_2_10_15_1 |
References_xml | – volume: 99 start-page: 956 year: 1990 end-page: 963 article-title: Predictability of the postoperative course of Crohn's disease publication-title: Gastroenterology – volume: 7 year: 2023 article-title: Impact of timing of primary ileocecal resection on prognosis in patients with Crohn's disease publication-title: BJS Open – volume: 10 start-page: 731 year: 2021 article-title: Early ileocecal resection is an effective therapy in isolated Crohn's disease publication-title: J Clin Med – volume: 20 start-page: e1040 year: 2022 end-page: e1049 article-title: A magnetic resonance imaging index to predict Crohn's disease postoperative recurrence: the MONITOR index publication-title: Clin Gastroenterol Hepatol – volume: 5 start-page: 900 year: 2020 end-page: 907 article-title: Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long‐term follow‐up of the LIR!C trial publication-title: Lancet Gastroenterol Hepatol – volume: 107 start-page: 1693 year: 2012 end-page: 1701 article-title: Surgery in a population‐based cohort of Crohn's disease from Olmsted County, Minnesota (1970‐2004) publication-title: Am J Gastroenterol – volume: 389 start-page: 1741 year: 2017 end-page: 1755 article-title: Crohn's disease publication-title: Lancet – volume: 26 start-page: 1303 year: 2007 end-page: 1312 article-title: Early versus late surgery for ileo‐caecal Crohn's disease publication-title: Aliment Pharmacol Ther – volume: 68 start-page: 423 year: 2019 end-page: 433 article-title: Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population‐based inception cohort: an Epi‐IBD study publication-title: Gut – volume: 4 start-page: 63 year: 2010 end-page: 101 article-title: The second European evidence‐based consensus on the diagnosis and management of Crohn's disease: special situations publication-title: J Crohns Colitis – volume: 18 start-page: 2512 year: 2008 end-page: 2521 article-title: Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopy publication-title: Eur Radiol – volume: 23 start-page: 2690 year: 2021 end-page: 2698 article-title: Patients' perceptions of surgery for inflammatory bowel disease publication-title: Color Dis – volume: 2 start-page: 785 year: 2017 end-page: 792 article-title: Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open‐label, multicentre trial publication-title: Lancet Gastroenterol Hepatol – volume: 13 start-page: 144 year: 2019 end-page: 164K article-title: ECCO‐ESGAR Guideline for Diagnostic Assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications publication-title: J Crohn's Colitis – volume: 33 start-page: 473 year: 2018 end-page: 477 article-title: Surgical recurrence in Crohn's disease: a comparison between different types of bowel resections publication-title: Int J Color Dis – volume: 68 start-page: 1774 year: 2019 end-page: 1780 article-title: Cost‐effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C trial publication-title: Gut – volume: 30 start-page: 1143 year: 2018 end-page: 1147 article-title: Risk factors for anastomotic recurrence after primary ileocaecal resection in Crohn's disease publication-title: Eur J Gastroenterol Hepatol – volume: 140 start-page: 1785 year: 2011 end-page: 1794 article-title: Epidemiology and natural history of inflammatory bowel diseases publication-title: Gastroenterology – volume: 165 start-page: 976 issue: 4 year: 2023 end-page: 985 article-title: Early ileocecal resection for Crohn's disease is associated with improved long‐term outcomes compared to anti‐tumor necrosis factor therapy: a population‐based cohort study publication-title: Gastroenterology – volume: 55 start-page: 872 year: 2023 end-page: 879 article-title: Disease course and treatment outcomes of Crohn's disease patients with early or late surgery—a Danish nationwide cohort study from 1997 to 2015 publication-title: Dig Liver Dis – volume: 390 start-page: 2769 year: 2017 end-page: 2778 article-title: Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population‐based studies publication-title: Lancet – volume: 19 start-page: 1602 year: 2021 end-page: 1610.e1 article-title: A scoring system to determine Patients' risk of colectomy within 1 year after hospital admission for acute severe ulcerative colitis publication-title: Clin Gastroenterol Hepatol – ident: e_1_2_10_16_1 doi: 10.1016/0016-5085(90)90613-6 – ident: e_1_2_10_8_1 doi: 10.1016/S2468-1253(20)30117-5 – ident: e_1_2_10_6_1 doi: 10.1111/codi.15813 – ident: e_1_2_10_4_1 doi: 10.1136/gutjnl-2017-315568 – ident: e_1_2_10_18_1 doi: 10.1093/ecco-jcc/jjy113 – ident: e_1_2_10_11_1 doi: 10.3390/jcm10040731 – ident: e_1_2_10_2_1 doi: 10.1016/S0140-6736(17)32448-0 – ident: e_1_2_10_20_1 doi: 10.1016/j.cgh.2021.06.035 – ident: e_1_2_10_22_1 doi: 10.1097/MEG.0000000000001206 – ident: e_1_2_10_13_1 doi: 10.1016/j.dld.2022.09.016 – ident: e_1_2_10_23_1 doi: 10.1007/s00384-018-2995-9 – ident: e_1_2_10_15_1 doi: 10.1016/j.cgh.2019.12.036 – ident: e_1_2_10_17_1 doi: 10.1016/j.crohns.2009.09.009 – ident: e_1_2_10_21_1 doi: 10.1093/bjsopen/zrad097 – ident: e_1_2_10_12_1 doi: 10.1111/j.1365-2036.2007.03515.x – ident: e_1_2_10_9_1 doi: 10.1136/gutjnl-2018-317539 – ident: e_1_2_10_14_1 doi: 10.1038/ajg.2012.298 – ident: e_1_2_10_19_1 doi: 10.1007/s00330-008-1034-6 – ident: e_1_2_10_5_1 doi: 10.1053/j.gastro.2011.01.055 – ident: e_1_2_10_3_1 doi: 10.1016/S0140-6736(16)31711-1 – ident: e_1_2_10_7_1 doi: 10.1016/S2468-1253(17)30248-0 – ident: e_1_2_10_10_1 doi: 10.1053/j.gastro.2023.05.051 |
SSID | ssj0006702 |
Score | 2.506579 |
Snippet | Summary
Background
Early complicated Crohn's disease (CD) may require ileal resection as first‐line treatment.
Aim
To evaluate the long‐term outcomes of... Early complicated Crohn's disease (CD) may require ileal resection as first-line treatment. To evaluate the long-term outcomes of patients who underwent early... Summary Background Early complicated Crohn's disease (CD) may require ileal resection as first‐line treatment. Aim To evaluate the long‐term outcomes of... BackgroundEarly complicated Crohn's disease (CD) may require ileal resection as first‐line treatment.AimTo evaluate the long‐term outcomes of patients who... Early complicated Crohn's disease (CD) may require ileal resection as first-line treatment.BACKGROUNDEarly complicated Crohn's disease (CD) may require ileal... Background: Early complicated Crohn's disease (CD) may require ileal resection as first-line treatment.Aim: To evaluate the long-term outcomes of patients who... |
SourceID | hal proquest crossref pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1388 |
SubjectTerms | Adult Crohn Disease - surgery Crohn's disease Crohns disease Diagnosis Female Human health and pathology Humans Hépatology and Gastroenterology Ileum - pathology Ileum - surgery Inflammatory bowel diseases Life Sciences Male Medical treatment Middle Aged Morphology Patients Recurrence Reoperation - statistics & numerical data Retrospective Studies Surgery Time Factors Treatment Outcome Young Adult |
Title | Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fapt.18247 https://www.ncbi.nlm.nih.gov/pubmed/39234950 https://www.proquest.com/docview/3119732600 https://www.proquest.com/docview/3100918834 https://hal.science/hal-04691632 |
Volume | 60 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61PSAuvB8LbWUQElyy2thO7NLTqlCtEEUVaqUekCLbsWlVlFSbLAdO_IT-xv4SZpwHFISEuEXJ2HE8nvgbe-YzwAvEwFypUiUz7lQijc0TK7VJRFaGXPtUqEBLAwcf8sWxfHeSnazB7pAL0_FDjAtuZBnxf00Gbmzzi5Gbi3aK4FhSJjlWSeFcbz7-pI7KVYw3RBdjJ-E6FT2rEEXxjCWvzUXrpxQJ-SfMvI5a47Szfxs-DQ3uok3Op6vWTt2337gc__OL7sCtHo6yeTd-7sKar-7BjYN-w_0-nEcCZIbVoRRlKsU0CHZWsb1lfVq9bFi_w8POGlbVLTO9un3JaImX4cTrl559qavPV98vaR5g9arFlvnmNcMxyiiilUWS2wdwvP_2aG-R9OczJE6kXCWmRLSp3U6mXSqVUzOXGY8etXUlIQ_hMmWJ7MbGg_8yo6QMNi0DxWgHbYJ4CBtVXfnHwKQXOnA_cwohhZihux-4S62wCJB0yPkEng-aKi46Go5icF-w24rYbSiEOhyfE3H2Yv6-oHu0CoDIk39NJ7A5qLjozbUpBG2mCuLqn8Cz8TEaGu2emMrXK5JBOJpqLeQEHnVDY3wVgkyBniaWfhUV_Pc2FvPDo3jx5N9Fn8JNjlCqy4DchI12ufJbCIVauw3rXB5ux5H_A_h9A9I |
link.rule.ids | 230,315,783,787,888,1378,11574,27936,27937,46064,46306,46488,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NatwwEB7yA20vJenvtmmjlkJzcVlLsqWUXJbQsGl3Qw4byM1IstQNLXbY9facR8gz9kk6I3tNQwn0ZqwRNjMazTfS6BPAB8TAXKlSJUPuVCKNzRMrtUlEVoZc-1SoQEsD07N8fCG_XmaXG3C0PgvT8kP0C27kGXG-JgenBem_vNxcN58QHUu1Cdsyx4FIvM7yvJ-HcxUrDjHJOEy4TkXHK0R1PH3XO9Foc061kP8Czbu4NQaekx143CFGNmpNvAsbvnoCD6bdnvhT-BE5ihl2RSk6TBRPKrCrih0v6nn1ccm6TRh2tWRV3TDTWcSXjFZhGcZGv_DsZ119_31zS1M1q1cNqsMvPzMcRoyKTlnkoX0GFydfZsfjpLtCIXEi5SoxJQJC7Q4z7VKpnBq6zHhMeq0rCRwIlylLfDQ23s2XGSVlsGkZqIw6aBPEc9iq6sq_BCa90IH7oVMY9cUQM_LAXWqFRQyjQ84H8H6tyuK6Zcoo1hkG6ruI-kYhVHLfTtzW49GkoHeUqCM45L_SAeytbVB0HrUsBO13CqLTH8C7vhl9gTY4TOXrFckgYky1FnIAL1rb9Z9CHCgwGcTeB9GY9_9jMTqfxYdX_y-6Dw_Hs-mkmJyefXsNjzgin_bA4h5sNYuVf4PIpbFv4wD9A2mY5k0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB61Raq4lH-6pYBBSHDJamM7sQunVctqgbaqUCv1gBTFjk2rVslqN8uBE4_AM_IkzDg_pSAkxC2K7cTxzMTf2DOfAV4gBuZKFSoacasimZs0MlLnkUgKn2oXC-VpaeDgMJ2eyPenyekKvOlyYRp-iH7BjSwj_K_JwGeF_8XI81k9RHAs1SrckCkiX0JEH6-4o1IVAg7Rx9iJuI5FSytEYTx902uT0eoZhUL-iTOvw9Yw70xuwaeux024ycVwWZuh_fobmeN_ftJt2GjxKBs3CnQHVlx5F9YP2h33e3ARGJAZPg5rUapSyINg5yXbnVdn5csFa7d42PmClVXN8lbermC0xstw5nVzxy6r8vOPb99pImDVssaeucVrhkrKKKSVBZbb-3AyeXu8O43aAxoiK2KuorxAuKntTqJtLJVVI5vkDl1qYwuCHsImyhDbjQkn_yW5ktKbuPAUpO117sUDWCur0m0Ck05oz93IKsQUYoT-vuc2NsIgQtI-5QN43kkqmzU8HFnnv-CwZWHYsBLKsC8n5uzpeD-je7QMgNCTf4kHsN2JOGvtdZEJ2k0VRNY_gGd9MVoabZ_kpauWVAfxaKy1kAN42KhG_ypEmQJdTWz9Kgj4733MxkfH4WLr36s-hfWjvUm2_-7wwyO4yRFWNdmQ27BWz5fuMcKi2jwJ6v8T6jIFwg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Early+ileal+resection+in+Crohn%27s+disease+is+not+associated+with+severe+long-term+outcomes%3A+The+ERIC+study&rft.jtitle=Alimentary+pharmacology+%26+therapeutics&rft.au=Grellier%2C+Nathan&rft.au=Kirchgesner%2C+Julien&rft.au=Uzzan%2C+Mathieu&rft.au=Mclellan%2C+Paul&rft.date=2024-11-01&rft.eissn=1365-2036&rft.volume=60&rft.issue=10&rft.spage=1388&rft_id=info:doi/10.1111%2Fapt.18247&rft_id=info%3Apmid%2F39234950&rft.externalDocID=39234950 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-2813&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-2813&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-2813&client=summon |